These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33795829)

  • 1. Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.
    Trilla-Fuertes L; Gámez-Pozo A; Maurel J; Garcia-Carbonero R; Capdevila J; G-Pastrián L; Mendiola M; Peña C; López-Vacas R; Cuatrecasas M; García-Alfonso P; Ramos-Ruiz R; Llorens C; Ghanem I; Conill C; Heredia-Soto V; Campos-Barros Á; Fresno Vara JÁ; Feliu J
    Sci Rep; 2021 Apr; 11(1):7402. PubMed ID: 33795829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02).
    Feliu J; Garcia-Carbonero R; Capdevila J; Guasch I; Alonso-Orduna V; Lopez C; Garcia-Alfonso P; Castanon C; Sevilla I; Cerezo L; Conill C; Quintana-Angel B; Sanchez ME; Ghanem I; Martin-Richard M; Lopez-Gomez M; Leon A; Caro M; Fernandez T; Maurel J
    Cancer Med; 2020 Feb; 9(3):1008-1016. PubMed ID: 31851776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
    Klas JV; Rothenberger DA; Wong WD; Madoff RD
    Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
    Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
    Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
    Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
    Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma.
    Zampino MG; Magni E; Leonardi MC; Santoro L; Petazzi E; Fodor C; Petralia G; Trovato C; Nolè F; Orecchia R
    BMC Cancer; 2011 Feb; 11():55. PubMed ID: 21291546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcome of simultaneous radiochemotherapy of anal carcinoma].
    Fraunholz IB; Adamietz IA; Lorenz M; Staib-Sebler E; Böttcher HD
    Zentralbl Chir; 1997; 122(1):39-43. PubMed ID: 9133135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.
    Wong CS; Tsao MS; Sharma V; Chapman WB; Pintilie M; Cummings BJ
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):309-14. PubMed ID: 10487550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis of epidermoid anal carcinoma regression after conservative treatment].
    Vorob'ëv GI; Odariuk TS; Orlova LP; Nechushkin MI; Rybakov EG
    Vopr Onkol; 2004; 50(6):663-7. PubMed ID: 15755059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.
    Gerard JP; Ayzac L; Hun D; Romestaing P; Coquard R; Ardiet JM; Mornex F
    Radiother Oncol; 1998 Mar; 46(3):249-56. PubMed ID: 9572617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
    Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
    Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
    Lancet; 1996 Oct; 348(9034):1049-54. PubMed ID: 8874455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases?
    Grabenbauer GG; Matzel KE; Schneider IH; Meyer M; Wittekind C; Matsche B; Hohenberger W; Sauer R
    Dis Colon Rectum; 1998 Apr; 41(4):441-50. PubMed ID: 9559628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiochemotherapy for anal carcinoma - effectivity and late toxicity.
    Mai SK; Grieger J; Lachmann R; Bohrer M; Tiefenbacher U; Wenz F
    Onkologie; 2002 Feb; 25(1):55-9. PubMed ID: 11893884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinoma.
    Rogers JE; Jácome AAA; Ohinata A; Wolff R; Morris VK; Johnson B; Mehdizadeh A; Rothschild ND; Ahmed SU; Guerra JL; Eng C
    Expert Rev Anticancer Ther; 2020 Oct; 20(10):901-908. PubMed ID: 32799569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced anal squamous cell carcinoma -- radiotherapy or surgery?
    Smigielski J; Rychter A; Fijuth J; Brocki M
    Chirurgia (Bucur); 2012; 107(5):626-30. PubMed ID: 23116837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.